In the United States, clinical trials are essential to medical innovation but remain largely hampered by difficulties in recruiting patients, which cause delays in the majority of studies. Participation relies heavily on trust in doctors and local facilities, particularly outside of large hospital centers. In this context, ObjectiveHealth's acquisition of a South Carolina-based company is part of a strategy to strengthen its local presence and expand its network. This location gives it direct access to local clinic and patient networks, which are often underrepresented in clinical trials due to the historical concentration of studies in large hospitals and the constraints associated with travel and the organization of clinical follow-up.
Piedmont Research Partners has over 15 years of experience in conducting late-stage clinical trials, particularly in key areas such as cardiovascular disease, endocrinology, rheumatology, gastroenterology, and immunology. By joining the ObjectiveHealth network, the center will contribute its medical expertise, its teams, and its local presence.
ObjectiveHealth's ambition is to bring clinical research closer to patients and healthcare professionals. To achieve this, the group relies on an integrated model that combines local research centers and digital tools designed to make trials faster and more reliable. In practical terms, these tools make it easier to identify patients eligible for a trial, reduce recruitment times, and monitor the progress of studies in real time.
